Show simple item record

Authordc.contributor.authorPorcal, Williams 
Authordc.contributor.authorHernández, Paola es_CL
Authordc.contributor.authorGonzález, Mercedes es_CL
Authordc.contributor.authorFerreira, Ana es_CL
Authordc.contributor.authorOlea Azar, Claudio es_CL
Authordc.contributor.authorCerecetto, Hugo es_CL
Authordc.contributor.authorCastro, Ana es_CL
Admission datedc.date.accessioned2010-01-13T17:27:24Z
Available datedc.date.available2010-01-13T17:27:24Z
Publication datedc.date.issued2008-09
Cita de ítemdc.identifier.citationJournal Medicinal Chemistry, 51 (19), pp 6150–6159, 2008en_US
Identifierdc.identifier.issn1520-4804
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/120850
Abstractdc.description.abstractNew 1,2,4-thiadiazolylnitrones and furoxanylnitrones were developed and evaluated as neuroprotective agents on a human neuroblastoma (SH-SY5Y) cells model. They inhibited at low micromolar concentrations the oxidative damage and the death induced by exposure to hydrogen peroxide. These heteroarylnitrones showed excellent peroxyl free radical absorbance capacities, analyzed by oxygen radical absorbance capacity (ORAC) assay with fluorescein as the fluorescent probe, ranging from 1.5- to 16.5-fold the value of the reference nitrone, R-phenyl-N-tert-butylnitrone (PBN). The electron spin resonance spectroscopy (ESR) demonstrated the ability of these derivatives to directly trap and stabilize oxygen, carbon, and sulfur-centered free radicals. These results demonstrated the potential use of these heteroarylnitrones as neuroprotective agents in preventing the death of cells exposed to enhanced oxidative stress and damage.en_US
Patrocinadordc.description.sponsorshipThe authors thank Collaborative Project UdelaR (Uruguay), CSIC (Spain) (Grant 2006UY0009), and Neuropharma S.A (Madrid, Spain). W.P. thanks Collaborative Project (Grant 2006UY0009) and CSIC (UdelaR) for fellowships.en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherAmerican Chemical Societyen_US
Títulodc.titleHeteroarylnitrones as Drugs for Neurodegenerative Diseases: Synthesis, Neuroprotective Properties, and Free Radical Scavenger Propertiesen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record